About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Regulatory and Clinical

Catalyst Category

Regulatory and Clinical

Live feed of every catalyst classified under Regulatory and Clinical.

CATALYSTS IN FEED

168

AVG MAX MOVE

+116.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

DSMB Efficacy Met FDA 510(k) Cleared FDA Approval FDA Fast Track FDA Meeting FDA Meeting Granted Generic Drug Approved Inconclusive Topline Results IND Cleared for Study IND Filed NDA Resubmission Orphan Drug Designation Positive Subgroup Data Positive Topline Results Primary Endpoint Met SPA Agreement Study Complete Trial Enrollment Complete

Range–Clear

2 catalysts

Regulatory and ClinicalDSMB Efficacy MetOct 6, 2026 · 7:30am ET

KAPAKairos Pharma, LTD.

Kairos Pharma Reports Positive Interim Efficacy Data from Phase 2 Trial of ENV-105

Company announced statistically significant results in metastatic prostate cancer treatment.

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+38.0%

RVOL

4.7x

Max high

$2.13

Fuel

3h 46m

Regulatory and ClinicalDSMB Efficacy MetOct 6, 2026 · 7:30am ET

KAPAKairos Pharma, LTD.+38.0%

Kairos Pharma Reports Positive Interim Efficacy Data from Phase 2 Trial of ENV-105

RVOL

4.7x

Max high

$2.13

Fuel

3h 46m

Regulatory and ClinicalDSMB Efficacy MetAug 28, 2026 · 6:01am ET

QNRXQuoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals Announces Private Placement Financing and Positive Interim Data

Company secures up to $50.0 million in financing and reports study progress.

Regulatory and ClinicalDSMB Efficacy MetAug 28, 2026 · 6:01am ET

QNRXQuoin Pharmaceuticals, Ltd.+64.6%

Quoin Pharmaceuticals Announces Private Placement Financing and Positive Interim Data

RVOL

11.6x

Max high

$10.80

Fuel

13m